Viewing Study NCT02025803


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-01-02 @ 9:17 AM
Study NCT ID: NCT02025803
Status: COMPLETED
Last Update Posted: 2024-09-05
First Post: 2013-12-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors
Sponsor: Taiho Oncology, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module